A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions

NCT05653869 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

RET-altered Solid Tumors

Interventions

DRUG: APS03118

Sponsor

Applied Pharmaceutical Science, Inc.